rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-24
|
pubmed:abstractText |
In systemic non-Hodgkin lymphoma (NHL), tumors that resemble germinal center B-cells are less aggressive than tumors that resemble postgerminal center B-cells. However, the value of B-cell differentiation markers in primary central nervous system lymphoma (PCNSL) is less clear. The objectives of this study were to characterize the immunophenotypes of PCNSL samples and to determine their utility in predicting clinical outcomes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-6
|
pubmed:meshHeading |
pubmed-meshheading:17999414-Adult,
pubmed-meshheading:17999414-Age Factors,
pubmed-meshheading:17999414-Aged,
pubmed-meshheading:17999414-Central Nervous System Neoplasms,
pubmed-meshheading:17999414-Disease-Free Survival,
pubmed-meshheading:17999414-Female,
pubmed-meshheading:17999414-Humans,
pubmed-meshheading:17999414-Immunohistochemistry,
pubmed-meshheading:17999414-Immunophenotyping,
pubmed-meshheading:17999414-Lymphoma,
pubmed-meshheading:17999414-Male,
pubmed-meshheading:17999414-Middle Aged,
pubmed-meshheading:17999414-Prognosis,
pubmed-meshheading:17999414-Proto-Oncogene Proteins c-bcl-6,
pubmed-meshheading:17999414-Survival Rate,
pubmed-meshheading:17999414-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.
|
pubmed:affiliation |
Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York, USA.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|